Al's Comment:

 They reported pretty good survivals for recurrent GBM. This experimental treatment is delivered via convection enhanced delivery for tumors that overexpress IL-4R, about 75% of recurrent glioblasomtas overexpress it. Unfortunately, I do not think there are any clinical trials open for it right now, but I will be keeping an eye on that.


Posted on: 05/08/2021

Medicenna posts positive data from mid-stage brain cancer study

 


Click HERE to return to brain tumor news headlines.


Our privacy / cookie policy has changed.
Click HERE to read it!